Aman Pande, MD

Appointed
2011

Education & Fellowships

Graduate School - Case Western Reserve University
Masters of Science in Clinical Research
Cleveland, OH United States
2024

Fellowship - State University of New York at Buffalo Affiliated Hospitals
Pulmonary and Critical Care Medicine
Buffalo, NY
2008

Residency - MetroHealth Medical Center
Internal Medicine
Cleveland, OH
2005

Medical Education - University of Delhi / University College of Medical Sciences, Delhi,
MBBS
India
1998

Professional Highlights

• Dr. Pande is certified by the American Board of Internal Medicine with additional subspecialty certification in Pulmonary Medicine as well as Critical Care Medicine.

Certifications

• Internal Medicine
• Internal Medicine - Pulmonary Disease
• Internal Medicine - Critical Care Medicine

Specialty Interests

Interstitial Lung Diseases including IPF, Hypersensitivity Pneumonitis and ILDs associated with Autoimmune diseases. The ILD diagnostic process and role of immunosuppressant agents in ILD management. Pulmonary and Extrapulmonary Sarcoidosis

Memberships

• Dr. Pande is a member of the member of the American Thoracic Society as well as the American College of Chest Physicians.

See publications for Aman Pande, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 6/26/2024, Dr. Pande has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Pande receives fees of $5,000 or more per year (or, in rare cases, equity or stock options) as a paid consultant, speaker or as a member of an advisory committee for the following companies:

• Boehringer Ingelheim

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.